GSK in China
We are in China, with China, for China.
As GSK and through our heritage companies, we have a 100-year legacy of helping to transform the health, lives and futures of people around China.
We have a presence across China with commercial operations in 250 cities, including 5 regional hubs in Beijing, Shanghai, Guangzhou and Hangzhou, 7 manufacturing sites in Nanjing, Shanghai, Shenzhen, Suzhou, Hangzhou and Tianjin and 1 global R&D centre in Shanghai.
Since 2010, we have achieved seven China Food and Drug Administration registrations in China.
Our joint ventures
Sino-American Tianjin SmithKline & French Laboratories (TSKF)
Established in 1987, TSKF is one of the earliest foreign-invested joint-venture consumer healthcare company by GSK, Tianjin Zhong Xin Pharm.Ltd. and Tianjin Medicinal Corporation.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. (Tianyuan)
Tianyuan is one of China's leading vaccine manufacturers and joined GSK Group in 2015 due to the 3-part deal with Novartis. Tianyuan is the important vaccines manufacture in China, producing and supply China and main markets with products that prevent illness against infectious diseases including influenza, meningitis and rabies.
learn more about
We provide innovative products in three primary areas of pharmaceuticals, vaccines, and consumer healthcare.